Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Establishment of NAFLD Cohort and Development of Fibrosis Markers — Stella

Home/Fibrosis of Liver/Establishment of NAFLD Cohort and Development of Fibrosis Markers

View on ClinicalTrials.gov

Recruiting

Back to Fibrosis of Liver trials

Establishment of NAFLD Cohort and Development of Fibrosis Markers

Trial locations(1 site)

South Korea

Seoul Metropolitan Government Seoul National University, Seoul

Key details

Sponsor

Seoul National University Boramae Hospital

Enrollment target

~1,000 participants

Started

January 2014

Primary completion

December 2029

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.